JPMorgan Chase & Co’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.2M Sell
1,741,456
-372,515
-18% -$6.24M ﹤0.01% 1499
2025
Q1
$32.5M Sell
2,113,971
-875,378
-29% -$13.5M ﹤0.01% 1390
2024
Q4
$65.9M Buy
2,989,349
+967,388
+48% +$21.3M ﹤0.01% 1033
2024
Q3
$36.4M Sell
2,021,961
-3,010,555
-60% -$54.3M ﹤0.01% 1357
2024
Q2
$81.8M Buy
5,032,516
+2,024,898
+67% +$32.9M 0.01% 925
2024
Q1
$42.4M Buy
3,007,618
+895,238
+42% +$12.6M ﹤0.01% 1259
2023
Q4
$22.1M Buy
2,112,380
+1,152,610
+120% +$12M ﹤0.01% 1575
2023
Q3
$9.79M Sell
959,770
-152,617
-14% -$1.56M ﹤0.01% 1982
2023
Q2
$8.38M Sell
1,112,387
-159,513
-13% -$1.2M ﹤0.01% 2160
2023
Q1
$11.3M Buy
1,271,900
+660,539
+108% +$5.85M ﹤0.01% 1910
2022
Q4
$5.58M Buy
611,361
+6,711
+1% +$61.2K ﹤0.01% 2307
2022
Q3
$4.88M Buy
604,650
+66,669
+12% +$538K ﹤0.01% 2351
2022
Q2
$4.05M Sell
537,981
-7,310
-1% -$55K ﹤0.01% 2545
2022
Q1
$5.12M Sell
545,291
-68,505
-11% -$643K ﹤0.01% 2540
2021
Q4
$4.92M Buy
613,796
+23,384
+4% +$187K ﹤0.01% 2600
2021
Q3
$5.75M Sell
590,412
-1,283,385
-68% -$12.5M ﹤0.01% 2490
2021
Q2
$18.6M Sell
1,873,797
-1,575,042
-46% -$15.6M ﹤0.01% 1686
2021
Q1
$39.8M Buy
3,448,839
+572,952
+20% +$6.61M 0.01% 1171
2020
Q4
$27.8M Sell
2,875,887
-1,409,275
-33% -$13.6M ﹤0.01% 1247
2020
Q3
$37.9M Buy
4,285,162
+1,505,871
+54% +$13.3M 0.01% 1004
2020
Q2
$34.3M Sell
2,779,291
-802,265
-22% -$9.89M 0.01% 970
2020
Q1
$32.2M Sell
3,581,556
-907,417
-20% -$8.15M 0.01% 916
2019
Q4
$44M Buy
4,488,973
+2,110,216
+89% +$20.7M 0.01% 922
2019
Q3
$16.4M Sell
2,378,757
-1,884,322
-44% -$13M ﹤0.01% 1499
2019
Q2
$38.7M Buy
4,263,079
+1,875,195
+79% +$17M 0.01% 988
2019
Q1
$37.4M Buy
2,387,884
+492,850
+26% +$7.73M 0.01% 1005
2018
Q4
$29.2M Sell
1,895,034
-186,515
-9% -$2.88M 0.01% 1042
2018
Q3
$44.8M Sell
2,081,549
-2,135,429
-51% -$46M 0.01% 965
2018
Q2
$103M Sell
4,216,978
-16,173,043
-79% -$393M 0.02% 604
2018
Q1
$348M Buy
20,390,021
+18,050,787
+772% +$308M 0.07% 270
2017
Q4
$44.3M Buy
2,339,234
+318,828
+16% +$6.04M 0.01% 943
2017
Q3
$34.7M Sell
2,020,406
-5,187,293
-72% -$89M 0.01% 1027
2017
Q2
$239M Sell
7,207,699
-575,544
-7% -$19.1M 0.05% 334
2017
Q1
$250M Sell
7,783,243
-1,144,919
-13% -$36.7M 0.06% 313
2016
Q4
$324M Sell
8,928,162
-1,767,337
-17% -$64.1M 0.08% 249
2016
Q3
$492M Buy
10,695,499
+3,424,656
+47% +$158M 0.12% 184
2016
Q2
$365M Buy
7,270,843
+1,664,452
+30% +$83.6M 0.09% 236
2016
Q1
$300M Buy
5,606,391
+729,668
+15% +$39M 0.08% 270
2015
Q4
$320M Buy
4,876,723
+927,447
+23% +$60.9M 0.08% 257
2015
Q3
$223M Sell
3,949,276
-591,802
-13% -$33.4M 0.06% 321
2015
Q2
$268M Buy
4,541,078
+1,074,001
+31% +$63.5M 0.06% 317
2015
Q1
$216M Sell
3,467,077
-42,379
-1% -$2.64M 0.05% 380
2014
Q4
$202M Sell
3,509,456
-434,387
-11% -$25M 0.05% 399
2014
Q3
$212M Buy
3,943,843
+130,325
+3% +$7.01M 0.05% 378
2014
Q2
$200M Buy
3,813,518
+322,446
+9% +$16.9M 0.05% 381
2014
Q1
$184M Buy
3,491,072
+222,880
+7% +$11.8M 0.05% 387
2013
Q4
$131M Sell
3,268,192
-210,791
-6% -$8.45M 0.04% 432
2013
Q3
$131M Sell
3,478,983
-333,610
-9% -$12.6M 0.04% 436
2013
Q2
$149M Buy
+3,812,593
New +$149M 0.05% 368